| scholarly article | Q13442814 |
| P2093 | author name string | Alan J Cooper | |
| Bashir A Lwaleed | |||
| William R Anderson | |||
| Brian R Birch | |||
| Neil M Harris | |||
| Lemke Z Solomon | |||
| P2860 | cites work | Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin | Q72706818 |
| P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine | Q73614987 | ||
| Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies | Q74429036 | ||
| Estramustine reversal of resistance to intravesical epirubicin chemotherapy | Q74625354 | ||
| Intravesical chemotherapy with epirubicin: a dose response study | Q77346914 | ||
| pH and chemotherapy. | Q30666336 | ||
| Effect of gamma-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell lines | Q30839018 | ||
| Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone | Q34741785 | ||
| Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin | Q35976413 | ||
| Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells | Q35981655 | ||
| n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. | Q36080066 | ||
| Nuclear transport as an ultimate step of multidrug resistance | Q40912107 | ||
| The use of valrubicin for the chemoresection of superficial bladder cancer -- a marker lesion study | Q43682104 | ||
| The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer | Q43953093 | ||
| Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy study | Q44066688 | ||
| Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent? | Q47708341 | ||
| The effect of fasting or desmopressin before treatment on the concentration of mitomycin C during intravesical administration. | Q51552804 | ||
| Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells. | Q54019742 | ||
| pH and drug resistance. II. turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs | Q61703293 | ||
| Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation | Q68277142 | ||
| Selective killing of human cancer cells by polyunsaturated fatty acids | Q69870720 | ||
| Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity | Q70301658 | ||
| Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group | Q70431293 | ||
| Chemoresection in Ta-T1 bladder cancer. Members of the EORTC Genito-Urinary Group | Q71496158 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 71-78 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma | |
| P478 | volume | 97 |
| Q38885404 | Blockade of a key region in the extracellular domain inhibits HER2 dimerization and signaling. |
| Q51284980 | Extractions of oil from Descurainia sophia seed using supercritical CO2, chemical compositions by GC-MS and evaluation of the anti-tussive, expectorant and anti-asthmatic activities. |
| Q33852049 | Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer |
| Q37599548 | New therapies for non-muscle-invasive bladder cancer |
| Q33982878 | Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions |
Search more.